Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESMany drugs being developed today focus on rare and genetic diseases, which often have very small populations, limited diagnostics, and no common treatment paths. This makes conventional recruiting methods ineffective, which can add months of even years to the recruiting process.
However, utilization of artificial intelligence and machine learning (AI/ML) can help sponsors accelerate the search process by finding undiagnosed and underdiagnosed patients with risk factors that mimic those who have been diagnosed. Combining these risk factors with effective genetic testing and counseling can help sponsors find and successfully recruit patients faster, cutting months from the trial life cycle. This paper explores how AI/ML technology and genetic testing can transform recruiting for rare disease research and give sponsors an edge in attracting participants to their trials.
The rare disease landscape Recruiting has always been one of the most difficult elements of clinical research. Even when a disease has millions of diagnosed patients and a well-established treatment path, finding patients who meet inclusion/exclusion criteria and convincing them to participate in a study is difficult. In rare disease research, that challenge is amplified. Rare diseases only affect a very small percentage of the population. The US Food and Drug Administration defines a disease as rare if less than 200,000 people in the US are affected (less than 0.06%) . The European Commission defines them as diseases that affect no more than 1 person in 2,000. Of the roughly 7000+ rare disease currently identified, it is estimated that roughly 80% are due to genetic causes; and 90% lack FDA approved treatments or therapies.
There is huge demand for treatments to address these unmet medical needs but finding study participants in order to run the trials is a constant challenge for sponsors. These diseases have small, dispersed populations with few specialists dedicated to the conditions, and most patients go years without getting an accurate diagnosis. That means study teams can go months before finding a single patient who fits the study criteria.
To solve this problem, life sciences companies need more targeted methods for finding patients, confirming diagnoses, and engaging them in conversations about the value of clinical study participation.
Getting the right outcomes from your clinical trials is all about the data and insights they provide. Biostatistics in clinical trials isn’t just a necessity, it can be a real competitive advantage.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
